Therefore, this study aimed to determine the expression profile of plasma leptin and its receptors in tumor tissue samples of patients with CP, explore the association between the leptin/leptin receptors axis and weight change, new-onset obesity, and confirm the prognostic value of leptin and its receptors in patients with CP. The gene discussed is LEPR; the disease is obesity due to melanocortin 4 receptor deficiency.